Cochlear Corporation — Englewood, Colorado

Cochlear Corporation is a clinical research site located in Englewood, Colorado, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Cochlear Corporation has participated in 1 clinical trials.

Therapeutic areas: Neurofibromatosis 2.

Sponsors: FDA Office of Orphan Products Development.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Englewood

Browse all research sites in Colorado · View every site in Englewood

• University Park Hematology Oncology
• University of Colorado Health Sciences Ctr
• Jewish Hospital
• Rocky Vista University
• Swedish Hospital
• University of Colorado | Steadman Hawkins Clinic Denver
• University Parks Hematology/Oncology
• Steadman Hawkins Clinic, University of Colorado Denver
• University of Colorado/Craig Hospital
• Craig Hospital
• Swedish Medical Center
• Mountain Blue Cancer Care Center - Swedish

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cochlear Corporation?

Cochlear Corporation has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cochlear Corporation conducted?

Cochlear Corporation has 1 clinical trials on record. Their work covers Neurofibromatosis 2.

Is Cochlear Corporation accredited by Crixeo Clinical Trials?

Cochlear Corporation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cochlear Corporation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.